Posted inBiotechnology
Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug
Argenx is spending $2.2 billion to absorb Forte Biosciences for its phase 2-stage vitiligo and celiac disease drug.
Posted inBiotechnology
Fabric Enables Multiple Stable Shapes Using Snap-Like Structural Design
Knitting has evolved beyond comfort wear. In a new study from Harvard SEAS, researchers demonstrate how ordinary weft knitting can…
Posted inBiotechnology
AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates
AstraZeneca executives told Fierce they are “very confident” in the pharma’s in-house pipeline of ADCs despite scrapping two candidates that…
Posted inBiotechnology
Fine-flavor native cacao matches commercial yields, study shows
A new multi-year field study from Peru’s Piura region challenges a long-held assumption in cocoa agriculture: native fine-flavor cacao may…
Posted inBiotechnology
Study uncovers ultrafast gene evolution driving chicken feather color diversity
Domestic chickens have long fascinated biologists with their feather diversity—ranging from barred and speckled patterns to uniform black and crisp…
Posted inBiotechnology
Saber-Toothed Cats’ Spinal Tumors Reveal How Inbreeding Threatened Survival
Saber-toothed cats (Smilodon fatalis) from the La Brea Tar Pits preserve more than just bones—they also retain a medical record…
Posted inBiotechnology
CCHFV Polymerase Enables RNA Synthesis and Shows Substrate Analog Inhibition
Viral polymerases of the Nairoviridae family are unusually large, and until now their atomic details have remained largely unexplored. In…
Posted inBiotechnology
Infection Study Maps Protein Contact Sites, Shows Influenza Hijacks Paraspeckles
Influenza A virus is infamous for its speed—yet the molecular choreography inside infected cells is still being uncovered. In a…
Posted inBiotechnology
Potassium Approaches Plasmonics’ Low Optical Loss Limit
Potassium is stepping into the spotlight as researchers report a new route toward the elusive low-loss performance limit in plasmonics.…
Posted inBiotechnology
Highly chemoselective access to alkyl-sulfur compounds via N2 extrusion of alkyl hydrazines
Sulfur(VI)-containing functional groups, such as sulfonamides, sulfinates and sulfonyl fluorides, are ubiquitous in pharmaceuticals, where they confer unique physicochemical properties…